- Home
- EXEL vs SEIC Comparison
EXEL vs SEIC Comparison
Compare EXEL & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- SEIC
- Stock Information
- Founded
- EXEL 1994
- SEIC 1968
- Country
- EXEL United States
- SEIC United States
- Employees
- EXEL N/A
- SEIC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- SEIC Investment Bankers/Brokers/Service
- Sector
- EXEL Health Care
- SEIC Finance
- Exchange
- EXEL Nasdaq
- SEIC Nasdaq
- Market Cap
- EXEL 9.7B
- SEIC 10.7B
- IPO Year
- EXEL 2000
- SEIC N/A
- Fundamental
- Price
- EXEL $36.20
- SEIC $83.48
- Analyst Decision
- EXEL Buy
- SEIC Hold
- Analyst Count
- EXEL 17
- SEIC 4
- Target Price
- EXEL $35.50
- SEIC $86.75
- AVG Volume (30 Days)
- EXEL 2.5M
- SEIC 622.1K
- Earning Date
- EXEL 02-04-2025
- SEIC 01-29-2025
- Dividend Yield
- EXEL N/A
- SEIC 1.14%
- EPS Growth
- EXEL 441.02
- SEIC 23.19
- EPS
- EXEL 1.55
- SEIC 4.15
- Revenue
- EXEL $2,081,598,000.00
- SEIC $2,052,819,000.00
- Revenue This Year
- EXEL $20.53
- SEIC $13.09
- Revenue Next Year
- EXEL $0.95
- SEIC $7.60
- P/E Ratio
- EXEL $23.39
- SEIC $20.11
- Revenue Growth
- EXEL 17.31
- SEIC 8.53
- 52 Week Low
- EXEL $20.02
- SEIC $62.38
- 52 Week High
- EXEL $37.59
- SEIC $87.25
- Technical
- Relative Strength Index (RSI)
- EXEL 58.54
- SEIC 57.01
- Support Level
- EXEL $33.05
- SEIC $77.57
- Resistance Level
- EXEL $37.59
- SEIC $82.69
- Average True Range (ATR)
- EXEL 0.99
- SEIC 1.47
- MACD
- EXEL 0.28
- SEIC 0.00
- Stochastic Oscillator
- EXEL 69.38
- SEIC 88.21
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2023, SEI (including LSV) manages, administers, or advises about $1.4 trillion in assets.